BioNexus Gene Lab Corp (BGLC)
0.5721
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.5721
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Revenue (Quarterly): 2.273M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.273M |
| September 30, 2023 | 2.554M |
| June 30, 2023 | 2.567M |
| March 31, 2023 | 2.377M |
| December 31, 2022 | 2.840M |
| September 30, 2022 | 2.575M |
| June 30, 2022 | 2.485M |
| March 31, 2022 | 3.029M |
| December 31, 2021 | 3.245M |
| September 30, 2021 | 3.576M |
| Date | Value |
|---|---|
| June 30, 2021 | 3.092M |
| March 31, 2021 | 3.449M |
| December 31, 2020 | 4.126M |
| September 30, 2020 | 3.091M |
| June 30, 2020 | 1.104M |
| March 31, 2020 | 3.07M |
| December 31, 2019 | 0.053M |
| September 30, 2019 | 0.0242M |
| June 30, 2019 | 0.0216M |
| March 31, 2019 | 0.0281M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0216M
Minimum
Jun 2019
4.126M
Maximum
Dec 2020
2.397M
Average
2.575M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Balchem Corp | 239.66M |
| Friedman Industries Inc | 115.97M |
| Solitario Resources Corp | -- |
| Golden Minerals Co | -- |
| Paramount Gold Nevada Corp | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.3085M |
| Total Expenses (Quarterly) | 2.015M |
| EPS Diluted (Quarterly) | 0.0096 |
| Enterprise Value | 4.210M |
| Gross Profit Margin (Quarterly) | 11.73% |
| Profit Margin (Quarterly) | 13.57% |
| Earnings Yield | -30.64% |
| Normalized Earnings Yield | -30.64 |